{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:02:49Z","timestamp":1786993369685,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jpsychores.2010.11.006","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T04:11:32Z","timestamp":1295151092000},"page":"13-17","source":"Crossref","is-referenced-by-count":37,"title":["Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression"],"prefix":"10.1016","volume":"71","author":[{"given":"Mariska","family":"Bot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene H.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Steinmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychores.2010.11.006_bb0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.psy.0000146294.82810.9c","article-title":"Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis","volume":"66","author":"van Melle","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","article-title":"Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis","volume":"66","author":"Barth","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0015","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2006.06.077","article-title":"Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events","volume":"48","author":"de Jonge","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PSY.0b013e31819b69e3","article-title":"History of depression and survival after acute myocardial infarction","volume":"71","author":"Carney","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1176\/appi.ajp.2008.08081239","article-title":"Treatment-resistant depression and mortality after acute coronary syndrome","volume":"166","author":"Carney","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0045","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hup.717","article-title":"IL-6 levels decrease with SSRI treatment in patients with major depression","volume":"20","author":"Basterzi","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/hrt.2005.075861","article-title":"Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome","volume":"92","author":"Shimbo","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0065","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2009.1487","article-title":"Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial","volume":"302","author":"Carney","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0070","series-title":"BDI-II: Beck Depression Inventory manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0075","first-page":"149","article-title":"The Hamilton rating scale for depression: a comprehensive review","volume":"10","author":"Hedlund","year":"1979","journal-title":"Journal of Operational Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.1103","article-title":"A psychoneuroimmunological review on cytokines involved in antidepressant treatment response","volume":"25","author":"Janssen","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2005.04.008","article-title":"Inflammatory markers in depressed post-myocardial infarction patients","volume":"39","author":"Schins","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0095","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","article-title":"Inflammatory markers and onset of cardiovascular events: results from the Health ABC study","volume":"108","author":"Cesari","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0100","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0105","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004850-200105000-00002","article-title":"The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial","volume":"16","author":"Schweizer","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0006-3223(95)00178-8","article-title":"Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo","volume":"38","author":"Fabre","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0125","series-title":"Refractory depression: current strategies and future directions.","first-page":"19","article-title":"Predictors of non-response to antidepressants","author":"Scott","year":"1995"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0130","series-title":"Treatment-resistant mood disorders","first-page":"3","article-title":"The characterization and definition of treatment-resistant mood disorders","author":"Souery","year":"2001"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0135","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archpsyc.65.8.870","article-title":"Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features","volume":"65","author":"Rush","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpsychores.2010.11.006_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0006-3223(02)01670-0","article-title":"Is treatment-resistant depression a unique subtype of depression?","volume":"53","author":"Fagiolini","year":"2003","journal-title":"Biol Psychiatry"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239991000440X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239991000440X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:20:15Z","timestamp":1559931615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239991000440X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S002239991000440X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2010.11.006","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}